T 1285/11 (Polymorphs/PFIZER) of 15.12.2011

European Case Law Identifier: ECLI:EP:BA:2011:T128511.20111215
Date of decision: 15 December 2011
Case number: T 1285/11
Application number: 08806952.1
IPC class: C07D 213/71
A61K 31/435
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 38 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Polymorphs of 3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-mehtyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof and methods for making the same
Applicant name: Pfizer Products Inc.
Opponent name: -
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention Art 113(1)
European Patent Convention Art 111(1)
European Patent Convention Art 82
European Patent Convention R 164(2)
European Patent Convention R 137(5)
European Patent Convention R 103(1)(a)
European Patent Convention R 71(2)
European Patent Convention R 44(1)
European Patent Convention 1973 R 86(4)
Keywords: Admissibility of amendments under Rules 137(5) and 164(2) EPC (yes)
Substantial procedural violation (yes) - lack of essential reasoning prior to refusal
Reimbursement of the appeal fee (yes)
Remittal (yes)


Cited decisions:
G 0002/92
J 0003/09
T 0951/92
T 0631/97
T 0708/00
Citing decisions:
T 2495/11
T 1981/12
T 0145/13

21 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Offical Journal of the EPO

Case Law Book: II Conditions to be met by an Application

Case Law Book: IV Divisional Applications

Case Law of the Enlarged Board

General Case Law